BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Goulart MR, Stasinos K, Fincham REA, Delvecchio FR, Kocher HM. T cells in pancreatic cancer stroma. World J Gastroenterol 2021; 27(46): 7956-7968 [PMID: 35046623 DOI: 10.3748/wjg.v27.i46.7956]
URL: https://www.wjgnet.com/1007-9327/full/v27/i46/7956.htm
Number Citing Articles
1
Matteo Ponzo, Anais Debesset, Mélissande Cossutta, Mounira Chalabi-Dchar, Claire Houppe, Caroline Pilon, Alba Nicolas-Boluda, Sylvain Meunier, Fabio Raineri, Allan Thiolat, Rémy Nicolle, Federica Maione, Serena Brundu, Carina Florina Cojocaru, Philippe Bouvet, Corinne Bousquet, Florence Gazeau, Christophe Tournigand, José Courty, Enrico Giraudo, José L. Cohen, Ilaria Cascone. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer ImmunosuppressionCancers 2022; 14(17): 4265 doi: 10.3390/cancers14174265
2
Sandeep Kumar, Sunil Kumar Singh, Piush Srivastava, Swathi Suresh, Basabi Rana, Ajay Rana. Pancreatic Cancer: Basic Mechanisms and TherapiesAdvances in Cancer Research 2023; 159: 113 doi: 10.1016/bs.acr.2023.02.003
3
Khandoker Usran Ferdous, Mulu Z. Tesfay, Aleksandra Cios, Randal S. Shelton, Conner Hartupee, Alicja Urbaniak, Jean Christopher Chamcheu, Michail N. Mavros, Emmanouil Giorgakis, Bahaa Mustafa, Camila C. Simoes, Isabelle R. Miousse, Alexei G. Basnakian, Omeed Moaven, Steven R. Post, Martin J. Cannon, Thomas Kelly, Bolni Marius Nagalo. Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic CancerBiomedicines 2024; 12(7): 1596 doi: 10.3390/biomedicines12071596
4
Patrick Schmidt, Johannes Lindemeyer, Pranali Raut, Markus Schütz, Sven Saniternik, Jannika Jönsson, Heike Endepols, Thomas Fischer, Alexander Quaas, Hans Anton Schlößer, Martin Thelen, Holger Grüll. Multiparametric Characterization of the DSL-6A/C1 Pancreatic Cancer Model in RatsCancers 2024; 16(8): 1535 doi: 10.3390/cancers16081535
5
Junzhu Dai, Yuxiang Han, Tianyi Fang, Hongxue Shao, Lei Teng, Huichao Zou. Clinical Significance of Mean Platelet Volume Combined with Neutrophil–Lymphocyte Ratio in Predicting the Therapeutic Effect of Splanchnic NeurolysisJournal of Inflammation Research 2023; : 5027 doi: 10.2147/JIR.S428641
6
Nabeel Merali, Maria-Danae Jessel, Edward H. Arbe-Barnes, Wing Yu Ruby Lee, Martha Gismondi, Tarak Chouari, James W. O'Brien, Bhavik Patel, Daniel Osei-Bordom, Timothy A. Rockall, Shivan Sivakumar, Nicola Annels, Adam E. Frampton. Impact of tertiary lymphoid structures on prognosis and therapeutic response in pancreatic ductal adenocarcinomaHPB 2024; 26(7): 873 doi: 10.1016/j.hpb.2024.04.009
7
Mengfei Li, Hongyu Chen, Dingchuan Peng, Xuehan Lu, Jianping Kong, Shujun Luo, Shiqi Li, Chunlu Tan, Ying Wang. FU-coating pH-sensitive liposomes for improving the release of gemcitabine by endosome escape in pancreatic cancer cellsJournal of Drug Delivery Science and Technology 2023; 80: 104135 doi: 10.1016/j.jddst.2022.104135
8
Behnia Akbari, Tahereh Soltantoyeh, Zahra Shahosseini, Farhad Jadidi-Niaragh, Jamshid Hadjati, Christine E. Brown, Hamid Reza Mirzaei. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancerFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1209572
9
Casper W.F. van Eijck, Jie Ju, Freek R. van ’t Land, Maaike Verheij, Yunlei Li, Andrew Stubbs, Michael Doukas, Karishma Lila, Lara R. Heij, Georg Wiltberger, Lola Alonso, Núria Malats, Bas Groot Koerkamp, Eveline E. Vietsch, Casper H.J. van Eijck. The tumor immune microenvironment in resected treatment-naive pancreatic cancer patients with long-term survivalPancreatology 2024;  doi: 10.1016/j.pan.2024.08.014
10
Ann Mary Joseph, Ahmad Al Aiyan, Basel Al-Ramadi, Shiv K. Singh, Uday Kishore. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinomaFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1323198
11
Dijana Perovic, Marija Dusanovic Pjevic, Vladimir Perovic, Milka Grk, Milica Rasic, Maja Milickovic, Tanja Mijovic, Petar Rasic. B7 homolog 3 in pancreatic cancerWorld Journal of Gastroenterology 2024; 30(31): 3654-3667 doi: 10.3748/wjg.v30.i31.3654
12
Uri Amit, Ugur Uslu, Ioannis I. Verginadis, Michele M. Kim, Seyyedeh Azar Oliaei Motlagh, Eric S. Diffenderfer, Charles-Antoine Assenmacher, Sandra Bicher, Sebastian J. Atoche, Edgar Ben-Josef, Regina M. Young, Carl H. June, Constantinos Koumenis. Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancerProceedings of the National Academy of Sciences 2024; 121(31) doi: 10.1073/pnas.2403002121
13
Milica Dimitrijevic Stojanovic, Bojan Stojanovic, Ivan Radosavljevic, Vojin Kovacevic, Ivan Jovanovic, Bojana S. Stojanovic, Nikola Prodanovic, Vesna Stankovic, Miodrag Jocic, Marina Jovanovic. Galectin-3’s Complex Interactions in Pancreatic Ductal Adenocarcinoma: From Cellular Signaling to Therapeutic PotentialBiomolecules 2023; 13(10): 1500 doi: 10.3390/biom13101500
14
Shamik Mascharak, Jason L. Guo, Deshka S. Foster, Anum Khan, Michael F. Davitt, Alan T. Nguyen, Austin R. Burcham, Malini S. Chinta, Nicholas J. Guardino, Michelle Griffin, David M. Lopez, Elisabeth Miller, Michael Januszyk, Shyam S. Raghavan, Teri A. Longacre, Daniel J. Delitto, Jeffrey A. Norton, Michael T. Longaker. Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinomaCell Reports Medicine 2023; 4(11): 101248 doi: 10.1016/j.xcrm.2023.101248
15
Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, Samuel Luca Rocha Pinheiro, Mariana dos Santos Calmon, Gabriel Lima Correa Santos, Gabriel Reis Rocha, Fabrício Freire de Melo. New avenues for the treatment of immunotherapy-resistant pancreatic cancerWorld Journal of Gastrointestinal Oncology 2024; 16(4): 1134-1153 doi: 10.4251/wjgo.v16.i4.1134
16
Songyu Guo, Zhenxia Wang. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategiesFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1349308
17
Sreejith T, Kaladhar Kamalasanan, Sneha S, Pavithran Keechilat, Hani Harb. Advancing Cancer Treatment Through Nanotechnology Driven Immunotherapy for Pancreatic CancerACS Applied Nano Materials 2023; 6(20): 18670 doi: 10.1021/acsanm.3c03454
18
Shichen Zhang, Na Ta, Shihao Zhang, Senhao Li, Xinyu Zhu, Lingyun Kong, Xueqing Gong, Meng Guo, Yanfang Liu. Unraveling pancreatic ductal adenocarcinoma immune prognostic signature through a naive B cell gene setCancer Letters 2024; 594: 216981 doi: 10.1016/j.canlet.2024.216981
19
Laura Miró, Júlia López, Pedro E. Guerrero, Neus Martínez-Bosch, Noemí Manero-Rupérez, Mireia Moreno, M. Rosa Ortiz, Esther Llop, Pilar Navarro, Rosa Peracaula. Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in MiceCancers 2022; 14(24): 6133 doi: 10.3390/cancers14246133
20
Chien-Yu Chou, Zhi-Qin Li, Hsiao-Chen Huang, Chung-Heng Hung, Shun-Long Weng, Shey-Cherng Tzou. Development of an Albumin-Masked mutPD-1Ig as a Tumor Lesion-Selective Immune Checkpoint InhibitorACS Omega 2023; 8(43): 40911 doi: 10.1021/acsomega.3c06216
21
Ashwin Jainarayanan, Nithishwer Mouroug-Anand, Edward H. Arbe-Barnes, Adam J. Bush, Rachael Bashford-Rogers, Adam Frampton, Lara Heij, Mark Middleton, Michael L. Dustin, Enas Abu-Shah, Shivan Sivakumar. Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T cellsiScience 2023; 26(4): 106324 doi: 10.1016/j.isci.2023.106324
22
Hang Yu, Wenting Zhu, Caiyan Lin, Menglei Jia, Xiaoxiao Tan, Zhongwen Yuan, Senglin Feng, Pengke Yan. Stromal and tumor immune microenvironment reprogramming through multifunctional cisplatin-based liposomes boosts the efficacy of anti-PD-1 immunotherapy in pancreatic cancerBiomaterials Science 2024; 12(1): 116 doi: 10.1039/D3BM01118F
23
Francesca R. Delvecchio, Rachel E.A. Fincham, Sarah Spear, Andrew Clear, Marina Roy-Luzarraga, Frances R. Balkwill, John G. Gribben, Michele Bombardieri, Kairbaan Hodivala-Dilke, Melania Capasso, Hemant M. Kocher. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in MiceCellular and Molecular Gastroenterology and Hepatology 2021; 12(5): 1543 doi: 10.1016/j.jcmgh.2021.06.023
24
Jason L. Guo, David M. Lopez, Shamik Mascharak, Deshka S. Foster, Anum Khan, Michael F. Davitt, Alan T. Nguyen, Austin R. Burcham, Malini S. Chinta, Nicholas J. Guardino, Michelle Griffin, Elisabeth Miller, Michael Januszyk, Shyam S. Raghavan, Teri A. Longacre, Daniel J. Delitto, Jeffrey A. Norton, Michael T. Longaker. Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic CancerTissue Engineering Part A 2024;  doi: 10.1089/ten.tea.2024.0039
25
Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, Maria Carmela Di Marcantonio, Mariagrazia Piscione, Raffaella Muraro, Gabriella Mincione. PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy StrategiesCancers 2023; 15(11): 2923 doi: 10.3390/cancers15112923
26
Ting Yang, Qiao-Qi Li, Yong-Mei Liu, Biao Yang. T cells in pancreatic cancer stroma: Tryptophan metabolism plays an important role in immunoregulationWorld Journal of Gastroenterology 2023; 29(17): 2701-2703 doi: 10.3748/wjg.v29.i17.2701
27
Othman Saleh, Hani Shihadeh, Ahmad Yousef, Hana Erekat, Fatima Abdallh, Ahmad Al-leimon, Rawan Elsalhy, Abdalrahman Altiti, Majd Dajani, Majd M. AlBarakat. The Effect of Intratumor Heterogeneity in Pancreatic Ductal Adenocarcinoma Progression and TreatmentPancreas 2024; 53(5): e450 doi: 10.1097/MPA.0000000000002342
28
Shreyas Gaikwad, Sanjay K. Srivastava. Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacyMolecular Therapy 2024; 32(9): 3145 doi: 10.1016/j.ymthe.2024.07.029
29
Julia Persky, Sylvia M. Cruz, Morgan A. Darrow, Sean J. Judge, Yueju Li, Richard J. Bold, Anthony N. Karnezis, Karen E. Matsukuma, Lihong Qi, Robert J. Canter. Characterization of natural killer and cytotoxic T‐cell immune infiltrates in pancreatic ductal adenocarcinomaJournal of Surgical Oncology 2024; 129(5): 885 doi: 10.1002/jso.27581
30
Sawsan Sudqi Said, Wisam Nabeel Ibrahim. Cancer Resistance to Immunotherapy: Comprehensive Insights with Future PerspectivesPharmaceutics 2023; 15(4): 1143 doi: 10.3390/pharmaceutics15041143
31
Jens von den Driesch, Jana Flöttmann, Friedrich Prall, Christina S. Mullins, Michael Linnebacher, Florian Bürtin. HROP68: A rare case of medullary pancreatic cancer—characterization and chemosensitivity of the first patient-derived cell lineFrontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1082927
32
Nnenna Elebo, Ebtesam A. Abdel-Shafy, Jones A. O. Omoshoro-Jones, Zanele Nsingwane, Ahmed A. A. Hussein, Martin Smith, Geoffrey Candy, Stefano Cacciatore, Pascaline Fru, Ekene Emmanuel Nweke. Comparative immune profiling of pancreatic ductal adenocarcinoma progression among South African patientsBMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12595-x
33
Fotini Poyia, Christiana M. Neophytou, Maria-Ioanna Christodoulou, Panagiotis Papageorgis. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future PerspectivesInternational Journal of Molecular Sciences 2024; 25(17): 9555 doi: 10.3390/ijms25179555
34
Angha Naik, Andrew Leask. Tumor-associated fibrosis impairs the response to immunotherapyMatrix Biology 2023; 119: 125 doi: 10.1016/j.matbio.2023.04.002
35
Lyanne Delgado-Coka, Michael Horowitz, Mariana Torrente-Goncalves, Lucia Roa-Peña, Cindy V. Leiton, Mahmudul Hasan, Sruthi Babu, Danielle Fassler, Jaymie Oentoro, Ji-Dong K Bai, Emanuel F. Petricoin, Lynn M. Matrisian, Edik Matthew Blais, Natalia Marchenko, Felicia D. Allard, Wei Jiang, Brent Larson, Andrew Hendifar, Chao Chen, Shahira Abousamra, Dimitris Samaras, Tahsin Kurc, Joel Saltz, Luisa F. Escobar-Hoyos, Kenneth R. Shroyer. Keratin 17 modulates the immune topography of pancreatic cancerJournal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05252-1
36
Sajid Khan, Vivekananda Budamagunta, Daohong Zhou. Pancreatic Cancer: Basic Mechanisms and TherapiesAdvances in Cancer Research 2023; 159: 145 doi: 10.1016/bs.acr.2023.02.004
37
Dae Ui Lee, Beom Seok Han, Kyung Hee Jung, Soon-Sun Hong. Tumor Stroma as a Therapeutic Target for Pancreatic Ductal AdenocarcinomaBiomolecules & Therapeutics 2024; 32(3): 281 doi: 10.4062/biomolther.2024.029